Zacks Research Downgrades Ascend Wellness (OTC:AAWH) to Strong Sell

Ascend Wellness (OTC:AAWH) was downgraded by analysts at Zacks Research from a “hold” rating to a “strong sell” rating in a research report issued to clients and investors on Tuesday,Zacks.com reports.

Ascend Wellness Price Performance

AAWH stock traded down $0.05 during midday trading on Tuesday, hitting $0.57. 13,040 shares of the stock were exchanged, compared to its average volume of 84,884. The stock’s 50-day moving average price is $0.67 and its 200-day moving average price is $0.66. The stock has a market cap of $116.82 million, a price-to-earnings ratio of -1.39 and a beta of 1.11. Ascend Wellness has a fifty-two week low of $0.26 and a fifty-two week high of $1.20. The company has a debt-to-equity ratio of 2.61, a quick ratio of 0.80 and a current ratio of 1.47.

Ascend Wellness Company Profile

Ascend Wellness Holdings, Inc engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods in the United States. The company offers flower, pre-rolls, concentrates, vapes, edibles, tinctures, and other cannabis-related products under the Common Goods, SimplyHerb, Ozone, Ozone Reserve, Royale, Tunnel Vision, Miss Grass, Lowell Smokes, Edie Parker, 1906, and AiroPro brands. It also owns, operates, and manages cannabis cultivation facilities and dispensaries. The company sells its products through company-owned retail stores and third-party licensed retail cannabis stores.